Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

A Comparison of 2-Phenyl-2-(1-piperidinyl)propane (PPP), 1,1′,1″-Phosphinothioylidynetrisaziridine (ThioTEPA), Clopidogrel, and Ticlopidine as Selective Inactivators of Human Cytochrome P450 2B6

Robert L. Walsky and R. Scott Obach
Drug Metabolism and Disposition November 2007, 35 (11) 2053-2059; DOI: https://doi.org/10.1124/dmd.107.015883
Robert L. Walsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Scott Obach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 35 no. 11 2053-2059
DOI 
https://doi.org/10.1124/dmd.107.015883
PubMed 
17682072

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received March 22, 2007
  • Accepted August 3, 2007
  • Published online October 18, 2007.

Article Versions

  • Earlier version (August 6, 2007 - 10:12).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Robert L. Walsky and
  2. R. Scott Obach
  1. Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton, Connecticut
  1. Address correspondence to:
    R. Scott Obach, Pfizer, Inc., Groton, CT 06340. E-mail: r.scott.obach{at}pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2007 to June 2022

AbstractFullPdf
Aug 2007510115
Sep 200713045
Oct 2007661388
Nov 2007341945
Dec 200751527
Jan 2008131223
Feb 200818722
Mar 200811517
Apr 2008151220
May 2008201415
Jun 2008101111
Jul 2008161520
Aug 2008221516
Sep 200824118
Oct 2008231010
Nov 2008172930
Dec 200892114
Jan 200941315
Feb 2009888
Mar 20098157
Apr 200981617
May 200951315
Jun 200991420
Jul 2009101916
Aug 200971317
Sep 2009111616
Oct 200991211
Nov 2009181014
Dec 20091867
Jan 201023219
Feb 2010182113
Mar 201020714
Apr 201026126
May 201021107
Jun 20101878
Jul 2010201311
Aug 20102388
Sep 2010231511
Oct 2010202210
Nov 2010131917
Dec 2010161610
Jan 2011231920
Feb 2011131210
Mar 2011899
Apr 20111098
May 2011101313
Jun 201118127
Jul 201123919
Aug 2011281318
Sep 201114815
Oct 2011192921
Nov 2011281417
Dec 2011111118
Jan 2012191712
Feb 2012211317
Mar 201237817
Apr 2012231417
May 2012151115
Jun 2012131316
Jul 2012272116
Aug 2012191412
Sep 2012121114
Oct 2012271313
Nov 2012131113
Dec 20121498
Jan 2013182213
Feb 2013171013
Mar 2013311417
Apr 2013281219
May 2013181120
Jun 20131049
Jul 2013141614
Aug 201310105
Sep 2013321715
Oct 2013122315
Nov 201321616
Dec 201318109
Jan 20145137
Feb 2014141313
Mar 2014162726
Apr 2014191914
May 2014111015
Jun 201461310
Jul 2014191811
Aug 201411610
Sep 2014171617
Oct 2014212122
Nov 20141388
Dec 2014847
Jan 20158911
Feb 201532116
Mar 2015201010
Apr 20152157
May 201520710
Jun 2015102215
Jul 2015131613
Aug 201516138
Sep 201515108
Oct 2015484
Nov 2015722
Dec 20159810
Jan 201691813
Feb 201671011
Mar 20163512
Apr 2016101417
May 2016211013
Jun 20169912
Jul 2016964
Aug 20166156
Sep 2016087
Oct 201622713
Nov 20161103
Dec 201641319
Jan 201702414
Feb 201701117
Mar 201703023
Apr 20170139
May 20170156
Jun 201701522
Jul 20170105
Aug 201713115
Sep 201702810
Oct 20170368
Nov 20171304
Dec 20173196
Jan 20181206
Feb 20180152
Mar 201812010
Apr 201802115
May 20180267
Jun 20180283
Jul 20180187
Aug 20181175
Sep 20181176
Oct 201824613
Nov 20180624
Dec 201842143
Jan 20196795
Feb 20194502
Mar 20191922
Apr 2019856
May 2019151112
Jun 20192285
Jul 2019734
Aug 20191381
Sep 20192011
Oct 20192122
Nov 20191823
Dec 2019653
Jan 20201644
Feb 20201854
Mar 20202144
Apr 20201461
May 20201154
Jun 20201533
Jul 2020500
Aug 2020333
Sep 20202825
Oct 20201963
Nov 20201623
Dec 20201401
Jan 2021694
Feb 20217217
Mar 20212043
Apr 2021941
May 20211040
Jun 20212181
Jul 20211323
Aug 20211431
Sep 20212351
Oct 20211343
Nov 20212233
Dec 20214521
Jan 20221562
Feb 2022542
Mar 20221932
Apr 20221731
May 20222132
Jun 20222334

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 35 (11)
Drug Metabolism and Disposition
Vol. 35, Issue 11
1 Nov 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Comparison of 2-Phenyl-2-(1-piperidinyl)propane (PPP), 1,1′,1″-Phosphinothioylidynetrisaziridine (ThioTEPA), Clopidogrel, and Ticlopidine as Selective Inactivators of Human Cytochrome P450 2B6
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

A Comparison of 2-Phenyl-2-(1-piperidinyl)propane (PPP), 1,1′,1″-Phosphinothioylidynetrisaziridine (ThioTEPA), Clopidogrel, and Ticlopidine as Selective Inactivators of Human Cytochrome P450 2B6

Robert L. Walsky and R. Scott Obach
Drug Metabolism and Disposition November 1, 2007, 35 (11) 2053-2059; DOI: https://doi.org/10.1124/dmd.107.015883

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

A Comparison of 2-Phenyl-2-(1-piperidinyl)propane (PPP), 1,1′,1″-Phosphinothioylidynetrisaziridine (ThioTEPA), Clopidogrel, and Ticlopidine as Selective Inactivators of Human Cytochrome P450 2B6

Robert L. Walsky and R. Scott Obach
Drug Metabolism and Disposition November 1, 2007, 35 (11) 2053-2059; DOI: https://doi.org/10.1124/dmd.107.015883
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • New Dog P450 3A98 in Gut
  • TMDD Affects PK of IL-10 Fc-Fusion Proteins
  • In Vitro Models to Study P-gp-Mediated Intestinal DDIs
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics